Natividade GR et al, Ocular Adverse Events with Semaglutide: A Systematic Review and Meta-Analysis
A propionyl L-carnitine-based drug is commercially available in Italy under the trade name Dromos , indicated for the treatment of obliterating arteriopathy of the lower limbs and for the therapy of chronic congestive heart failure in order to increase the tolerance of physical effort (see also patent GB 2,008,578)
In a trial of adult patients with type 2 diabetes and body mass index (BMI) greater than or equal to 27 kg/m 2 for weight reduction (Study 3), hypoglycemia (defined as a plasma glucose less than 54 mg/dL) was reported in 6.2% of WEGOVY-treated patients versus 2.5% of placebo-treated patients
Nonoperative Management of Uncomplicated Appendicitis
Retrieved from NCBI Bookshelf: (Comprehensive overview of indications, mechanism of action for methemoglobinemia, dosing, and safety considerations for methylene blue)
A dedicated care team physicians, dietitians, and health coaches working together so members are on the right drug, with the right support, and sustained results
